SLC7A11 and lung carcinoma: Importantly, targeting SLC7A11 using its inhibitor, erastin, showed obvious inhibition on the colony formation of lung cancer cells and cancer development with ELF3 overexpression and PTEN deficiency by inducing ferroptosis (Fig. 7).